Neuroprotective agent

WO2025243724A1PCT designated stage Publication Date: 2025-11-27NAT CENT OF NEUROLOGY & PSYCHIATRY +2
-1 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2025/014413
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-20
Filing Date
2025-04-11
Publication Date
2025-11-27

Smart Images

  • Figure JP2025014413_27112025_PF_FP_ABST
    Figure JP2025014413_27112025_PF_FP_ABST
Patent Text Reader

Abstract

Provided are: a novel compound which is useful for the treatment of diseases to be prevented, ameliorated, and / or treated by suppressing axon degeneration; and a pharmaceutical composition containing the same.　The present invention pertains to: a compound represented by general formula (I) [in the formula, R1, R2, R3, X1, X2, X3, X4, X5, Y1, Y2, Z1, and a ring C are as described in the specification and the claims] or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition containing the same.
Need to check novelty before this filing date? Find Prior Art